When was lokelma approved?

When did Lokelma (sodium zirconium cyclosilicate) get FDA approval?

Lokelma was approved by the U.S. Food and Drug Administration (FDA) on May 18, 2018 for the treatment of hyperkalemia in adults. [1]

Did Lokelma have earlier approvals outside the U.S.?

The FDA approval date above is specific to the U.S. approval. If you meant a first approval in another country (such as the EU), the date may differ by regulator and indication.

What strength and dosing form did FDA approve at launch?

At launch, Lokelma was approved as sodium zirconium cyclosilicate in an oral powder for suspension (sachets), intended to bind potassium in the gastrointestinal tract. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/lokelma